A brand new direction in the field of vital pulp therapy is given by the introduction of tissue engineering as an emerging scientific field. It aims to regenerate a functional tooth-tissue structure by the interplay of three basic key elements: stem cells, morphogens and scaffolds. It is a multidisciplinary approach that combines the principles of biology, medicine, and engineering to repair and/or regenerate a damaged tissue and/or organ. This two part article reviews and discusses the basic concept and strategies so far studied and researched for the engineering of basic dental tissues, to restore a functional tooth anatomy. This first part focuses on a detailed description of key elements used in tissue engineering and their applied clinical applications in dentistry. The second part will deal with the strategies that are being used and/or developed to regenerate the tooth tissues with the help of this scientific principle. Clinical Relevance: The field of tissue engineering has recently shown promising results and a good future prospect in dentistry for the development of the most ideal restorations to replace the lost tooth structure with a functional replacement. Dent Update 2009; 36: XXX-XXX
The discipline of 'tissue engineering' is a multidisciplinary approach that combines many of the basic principles of biology, medicine and engineering. The primary goal is the restoration, maintenance and enhancement of tissue and/or organ function along with diagnostic applications. The term was coined at a meeting sponsored by the 'National Institutes of Health' in 1987. It translates fundamental knowledge in physics, chemistry, biology, biomaterials, cell biology, stem cell research, 3-D engineered structures, biomechanical science, biomolecules and growth factors into materials, devices and strategies to repair or regenerate a damaged tissue and/or organ at cellular and molecular level. 1 In dentistry, various classes of implant/transplant materials (bone graft material) have been developed and used in recent times. Tissue/organ transplants can be broadly classified into four basic categories:
An autograft is a tissue or organ that is moved from one location to another within a single individual. It is considered the 'gold standard' for success as it avoids complication from immunological reactions.  Allograft Allografts are tissues or organs that are transplanted from one individual to another within the same species. Frozen blood, bone, skin, corneas, ligaments and tendons are routinely used for future surgical procedures.
 Xenograft
Xenotransplants are transplantation, implantation or infusion into a human recipient of either (a) live cells, Alloplasts are composed of synthetic materials. Procedures in dentistry involving alloplast materials (metal and ceramic dental implants) are becoming increasingly common. They show no adverse immunological reactions and pose no risk of disease transmission.
True 'biological biomaterials' are ones that lead to biological and/or natural tissue restoration. Recently, leading edge synthetic biomaterials (bonding, composites, cements, and ceramics) have been fabricated to be utilized in chairside dental applications along with state-of-the-art strategies and technologies (tissue engineering, nanoengineering, self-assembling systems) 3 ( Figure 1 ).
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Definition of tissue engineering
Tissue engineering is the field of functional restoration of tissue structure and physiology for impaired or damaged tissues because of cancer, diseases and trauma. 4 It requires the three key elements:  Progenitor/stem cells;  Inductive morphogenetic signals 5, 6 in an environment conductive to regeneration of a vital and functional tissue and/or organ;  An extracellular matrix scaffold (which can be synthetic) (Figure 2 ).
Key elements of tissue engineering Stem cells
Stem cells are defined as c1onogenic unspecialized cells capable of both self-renewal for long periods and multi-lineage differentiation, contributing to regenerate specific tissues. 7 They aid replacement of cells that are lost through normal wear, injury or disease. The ideal source for the stem cells is the patient. There are different types of stem cells within the body, many of which are being used for the purpose of tissue engineering of dental tissues.
Embryonic stem cell (pleuripotent cells)
Embryonic stem cells are derived from embryos (blastocysts) and are pleuripotent, ie they have the capacity to form all tissues. The cells of the inner cell mass of the blastocyst contribute to all tissues of the adult, eg foetal stem cells are pleuripotent. Successful culture of stem cells from human embryos was reported for the first time in 1988 by Thomson. 8 These can be exposed to specific combinations of growth and differentiation factors in vitro, to induce their differentiation in desired directions, or could be directly implanted into the patient's tissues, where they would then differentiate into specific cell types after encountering the appropriate niche.
Adult stem cells (multipotent cells)
Adult stem cells are undifferentiated cells that typically generate the cell types of the tissue in which they reside. For example, adult mesenchymal (or stromal) stem cells. Multipotential adult stem cells differentiate into endothelium, neuroectoderm and endoderm in vitro under defined culture conditions. They are limited to forming specific tissues only and exhibit the property of transdifferentiation or November 2009 plasticity. 9, 10, 11 Stem cells are thought to reside in a specific area of each tissue where they may remain quiescent for many years until they are activated by disease or tissue injury. These adult stem cells are present in brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, skin, liver and dental pulp.
Dental pulp stem cells (DPSC)
Post-natal stem cells have been found more recently, and are mesenchymal in nature. 12, 13 i. Dental pulp stem cells (DPSC), like osteoblasts, express bone markers such as bone sialoprotein, alkaline phosphatase, type I collagen, and osteocalcin. 14, 15 Various bone formation regulators, including TGF-β and others cytokines, are members that regulated their differentiation.
ii. The in vitro experiments of colony-forming efficiency and cell proliferation from dental pulp tissue and bone marrow indicated that the incidence of colony-forming cells is more clonogenic in dental pulp than in bone marrow.
iii. According to Gronthos et al, 16 the DPSCs have the ability to regenerate the dentin-pulp-like complex.
Stem cells from human exfoliated deciduous teeth (SHED) 1,17
The ethical concern regarding the utilization of embryonic stem cells in the tissue engineering and cells therapies have led to research being oriented towards auxiliary resources of human stem cells. High quality human stem cells have recently been found in the exfoliated human primary teeth. 17 These new cells have been termed SHED (Stem Cells from Human Exfoliated Deciduous Teeth). They possess high proliferative and clonogenic capacity, and capacity to be differentiated into a variety of other cell types, including neural cells and odontoblasts. In comparison with DPSCs, SHED showed a significantly higher proliferation rate. But in vivo these cells failed to reconstitute a dentin-pulp-like complex.
Stem cells from the apical papilla (SCAP)
A recent scientific finding has attributed the process of apexogenesis to occur due to the presence of mesenchymal stem cells (MSCs) residing in the apical papilla of incompletely developed teeth. 18, 19 These can differentiate into odontoblastlike cells, forming dentin when implanted in immunocompromised mice using hydroxyapatite/tricalcium phosphate (HA/ TCP) as a carrier vehicle. 18 It is likely that, along with HERS (Hertwig Epithelial Root Sheath), SCAP cells are also important for the continued root development after transplantation, and that odontoblast lineages can also be derived from stem cells in apical papilla. SCAP cells are also highly likely to survive after transplantation because minimal vascularity is found in the apical papilla, based on preliminary findings. 19 A recent review 20 discussed their potential role in the contribution of the continued root maturation in endodontically treated immature teeth with periradicular periodontitis or an abscess, as well as in autotransplanted teeth; their role in the survival of dental pulp was advocated along with DPSCs.
Periodontal ligament stem cells (PDLSCs)
These cells have been shown to possess the multipotent nature of a typical adult stem cell. 21 The combination of SCAP and periodontal ligament stem cells (PDLSCs) are being used for bioroot engineering in a swine model 19 that has the potential to replace dental implants in future clinical settings.
Dentinal repair in a post-natal organism occurs through the activity of specialized cells called odontoblasts. Dentin matrix can be considered a reservoir of growth factors, 22 such as transforming growth factors (TGF-β), bone morphogenic protein (BMP), fibroblast growth factor (FGF) and insulin-like growth factor (IGF). 23, 24 These factors are released after dentin demineralization by the caries process. They appear to be involved in the proliferation and differentiation of pulp cells, providing chemotactic signals to recruit progenitor pulp cells at the injury site and to initiate tissue repair. 25 The injured endothelial cells of dental pulp release chemotactic factors, signalling molecules to initiate the inflammatory process and expression molecules necessary for initiating the healing process.
Morphogens
Morphogens are extracellularly secreted signals governing morphogenesis during epithelial-mesenchymal interactions. The morphogenetic signalling networks include the five major classes of evolutionarily conserved genes: 26, 27  Bone morphogenetic proteins (BMPs);  Fibroblast growth factors (FGFs);  Wingless-and int-related proteins (Wnts);  Hedgehog proteins (Hhs);  Tumour necrotic factor (TNF).
Among all the families, BMPs are extensively studied and appear to be sufficient for tooth regeneration in adults. 6 Their role in tissue engineering has been emphasized by two major views as seen from the literature, ie reparative processes that recapitulate early developmental events and the potential multifunctional nature of ECM molecules. Induction of odontoblasts involves signalling from the epithelium to synthesize extracellular matrix proteins which establish an epithelial-mesenchymal crosstalk, leading to dentin formation and tooth morphogenesis. This crosstalk is mediated by diffusible molecules (BMPs) and their specific receptors (BMPRs) present in cells. These receptors cause the activation of intracellular machinery to secrete extracellular matrix proteins by odontoblasts that will eventually lead to the mineralization of dentin. These events therefore require a source cell, to produce the signalling molecule, another cell that is responsive to it, and the one that expresses the specific receptor that also possesses the 'machinery' to make the required protein. 28 Among the various Bone Morphogenetic Proteins (BMPs), 10 BMP members [BMP2, BMP4, BMP6, BMP7, BMP8, Growth/differentiation factors (Gdf1, Gdf5, Gdf7, Gdf6, Gdf11)] and glial cell line-derived neurtrophic factor (GDNF) are being cloned from rat incisor pulp.
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BMP4 from the epithelium induces the mesenchyme to be odontogenic. BMP2, BMP4 and BMP7 signals, expressed in the enamel knot, influence both epithelial and mesenchymal cells. BMP2, BMP4, BMP6, BMP7 and Gdf11 are also expressed during odontoblast differentiation and BMP4 and BMP5 during ameloblast differentiation. 30, 31 BMP7 (osteogenic protein-1) is used as a lining agent on exposed pulp to induce reparative dentin formation. 32 Similar BMP studies have concluded that TGF-β may also induce reparative dentin formation and plays an important role in tooth November 2009
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TissueEngineering development during the embryonic stage and has potential application to regenerate dentin-pulp complex. 23, 33 Amelogenin accounts for 90% of the enamel matrix mineral. Mutations in the gene amelogenin have been shown to cause enamel hypoplasia. 34 More recently, signalling effects have also been well documented, with the amelogenin gene splice products, A+4 (8.1-kd) and A-4 (6.9-kd), which are two small molecular weight products. 35 Research studies have observed that implantation of A+4 leads to the formation of a thick and homogeneous dentinal bridge in the crown and root of the teeth. Implantation of A-4 showed diffuse mineralization of the coronal pulp space and homogeneous reparative dentin layer of the root canal. After either A+4 or A-4 implantation, two groups of cells differentiated simultaneously, ie odontoblasts and osteoblasts. 36 In vivo implantation at ectopic sites (gingiva of mice) of A+4 or A-4 showed no mineralization after implantation. 37 Bone sialoprotein, Dentin matrix protein-1, Dentin sialo phosphoprotein and Osteopontin are grouped as a family of Small Integrin-Binding Ligand N-linked Glycoproteins (SIBLING). 38 Dentin phosphoprotein (DPP), also named phosphophoryn, is a molecule that triggers dentine mineralization and plays a role in mineral nucleation, cell differentiation and other novel signalling functions 39 . Dentin sialo phosphoprotein (DSPP) is a protein derived from the same gene as DPP. It is observed that the mutations in the gene encoding for this morphogen can lead to the condition called as 'dentinogenesis imperfect' . 40 Bone sialoprotein (BSP) is a phosphorylated protein that promotes the formation of a reparative tissue and enhances the fibrillogenesis of collagen. 41 Dentin matrix protein (DMP)-1 induces the differentiation of mesenchymal cells to odontoblast-like cells. 42 Dentonin (also known as AC-100) is a peptide derived from the matrix extracellular phosphorylated glycoprotein. It is a 23-amino acid fragment that stimulates the proliferation and differentiation of pulp stem cells in vitro 43 and massive formation of reparative dentin. 37 Other growth factors identified in dentin that aid in tissue regeneration includes, MMPs (matrix metalloproteinases) 44 , TGF-β 45 , IGF-1 and -2, FGF-2 38 and various angiogenic growth factors. 46 
Biomaterials and scaffolds
The scaffold provides a physicochemical and biological 3-D microenvironment for cellular migration, adhesion, growth and differentiation. It acts as a carrier for morphogens in cell therapy. Scaffold should be effective for transportation of nutrients, oxygen and waste. It should gradually be degraded and replaced by regenerating tissue. It should also retain the feature of the final tissue structure during the regeneration process. 4 So far, scaffolds and carrier systems have used three types of biomaterials: natural (or biological) materials, ceramic or glass materials, and polymeric materials. 1 Ideal requirements of scaffold materials as biomechanical structures are: 1, 47  Should not elicit any toxic or immunogenic response in host;  Should have controlled biodegradability;  Should be amenable to surgical sterilization;  Should have adequate mechanical performance in load-bearing situations;  Should be sufficiently porous to permit migration and growth of cells into their interior, along with the development of a new fractal circulatory system to promote the exchange of metabolic waste.
Biological/natural polymers offer good biocompatibility and bioactivity. Examples of natural materials include collagen, glycosaminoglycan, lyophilized bone (both allogenous and xenogenous) and coral. Collagen, along with freeze-dried bone, induces local endochondral bone formation in conjunction with growth factors in vivo. Coral, when treated with phosphoric acid, leads to the formation of calcium phosphate material which is very strong and biocompatible. With this method there is high potential for viral, prion and disease transmission in vivo. Certain types of glasses, glass-ceramics and pure ceramics can form an intimate bond with living bone tissue. Hydroxyapatite, the major inorganic constituent of bone, is commonly used as a bone augmentation scaffold. Ceramic and glass-ceramic materials can provide some of the mechanical performance needed in these sites and are generally biocompatible. However, their long degradation time in vivo and lack of native porosity have limited their use as scaffolds. Recent investigations into nanoporous and nanoparticulate sol-gel synthesis methods for glasses and ceramics may overcome some of these limitations in the near future. Presently, the most common material used to build tissue-engineering scaffolds are polymers. These substances include polylactic acid, polyglycolic acid (and co-polymers of these two) (PGA), polycaprolactone, poly(lacticco-glycolic acid) (PLGA), synthetic hydrogels including poly(ethylene glycol) (PEG)-based polymers, and those modified with cell surface adhesion peptides, such as arginine, glycine, and aspartic acid. 1, 48, 49 These materials are metabolized in vivo, and their acidic degradation products are easily removed from the body. However, problems associated with polymers include inflammation around the implantation site owing to the acidic and toxic degradation products, difficulty in precisely controlling the time of survival in the body, and stiffness of the material during degradation.
Various other materials have also been tried and tested as scaffold structures:  Fibronectin that mediates the binding of signalling molecules and plays a role in interactions between extracellular matrix and cells; 50  Collagen allows the arrangement of preodontoblasts and binds newly formed odontoblasts to pulp tissue, supporting a reparative dentinogenesis framework; 51  Synthetic extracellular matrix may also be a potential scaffold for reparative dentinogenesis;  Alginate hydrogel facilitates pulpal wound healing; 52  MTA powder sets in the presence of moisture, prevents microleakage, is biocompatible and promotes reparative dentin formation 53 and  Fibrous titanium mesh and biodegradable porous calcium phosphate have also been tested.
Conclusion
Tissue engineering requires the three key elements, stem cells, morphogens and scaffolds to combine together to form the basic framework for the formation of engineered tooth tissues. In Part 2 of this review the main strategies that are being used and/or developed to regenerate the tooth tissues with the help of this scientific principle will be explored.
